Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference) Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference)

Evolving Lipoprotein Risk Factors: Lipoprotein(A) and Oxidized Low-Density Lipoprotein (Beckman Conference‪)‬

Clinical Chemistry 1998, August, 44, 8

    • $5.99
    • $5.99

Publisher Description

Atherosclerosis is the major cause of cardiovascular disease and death in Western civilizations (1). The atherosclerotic lesion typically comprises fatty streaks that later develop into fibrous plaques. The initial fatty streaks are characterized by the presence of lipid-laden foam cells, mainly macrophage in origin. Fatty streaks may regress or progress via a transitional lesion to fibrous plaques. The fibrous plaque represents the most characteristic lesion of advancing atherosclerosis. The fibrous plaque consists of a fibrous cap made up of smooth muscle cells and dense connective tissue, an underlying cellular layer, and a deeper necrotic core. The fibrous plaque may undergo changes such as calcification, necrosis, hemorrhage, ulceration, or thrombosis to form a complicated lesion. These complicated lesions produce the clinical manifestations of atherosclerosis. Oxidized LDL

GENRE
Science & Nature
RELEASED
1998
August 1
LANGUAGE
EN
English
LENGTH
18
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
193.4
KB

More Books Like This

High-Density Lipoproteins High-Density Lipoproteins
2011
The HDL Handbook The HDL Handbook
2017
Report of the National Heart, Lung, And Blood Institute Workshop on Lipoprotein(A) and Cardiovascular Disease: Recent Advances and Future Directions (Special Report) (Clinical Report) Report of the National Heart, Lung, And Blood Institute Workshop on Lipoprotein(A) and Cardiovascular Disease: Recent Advances and Future Directions (Special Report) (Clinical Report)
2003
Apolipoprotein A5 and Hypertriglyceridemia (Editorials) Apolipoprotein A5 and Hypertriglyceridemia (Editorials)
2005
Atherogenic Index of Plasma [Log(Triglycerides/Hdl-Cholesterol)]: Theoretical and Practical Implications (Editorial) Atherogenic Index of Plasma [Log(Triglycerides/Hdl-Cholesterol)]: Theoretical and Practical Implications (Editorial)
2004
Lipoproteins as Carriers of Pharmacological Agents Lipoproteins as Carriers of Pharmacological Agents
2017

More Books by Clinical Chemistry

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics) High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics)
2008